Mount Sinai Genomics is a Connecticut-based medical genetics practice at the Mount Sinai Health System.
June 17, 2021
February 10, 2021
Sema4, in taking steps to become a public company, enters into an agreement with CM Life Sciences, a special purpose acquisition company.